Insiders · RNAC

Michael Singer

Director at Cartesian Therapeutics, Inc. (RNAC) since November 2023

Michael Singer has filed 10 insider reports with the SEC since November 2023, as director at Cartesian Therapeutics, Inc. (RNAC). The latest filing, on March 13, 2026, reports gift at Cartesian Therapeutics, Inc. (RNAC).

Filings
10
Companies
1
Bought on market
None
Sold on market
None

Companies where Michael Singer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cartesian Therapeutics, Inc. logo
RNAC
Cartesian Therapeutics, Inc.
Directorsince November 202349,578$6.14Mar 13, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Michael Singer with

Other insiders at the same companies

Questions about Michael Singer

What is Michael Singer's role at Cartesian Therapeutics, Inc.?
Michael Singer reports to the SEC as director at Cartesian Therapeutics, Inc. (RNAC), according to the latest filing on March 13, 2026.
How many shares does Michael Singer own?
After the latest filing that states it, Michael Singer directly owned 49,578 shares of Cartesian Therapeutics, Inc. (RNAC). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Singer bought or sold stock recently?
No open-market purchases or sales by Michael Singer are on file. The filings report gift, grant or award, exercise or conversion of a derivative and other acquisition or disposition.
How do I get alerts when Michael Singer files?
Follow Michael Singer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Michael Singer (SEC CIK 0002000122). Totals count each trade once, skipping amendments whose original is on file, from Nov 15, 2023 on. View on SEC EDGAR · Get this as JSON